Vanguard Group’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.69M | Hold |
706,733
| – | – | ﹤0.01% | 3590 |
|
|
2025
Q1 | $3.04M | Hold |
706,733
| – | – | ﹤0.01% | 3347 |
|
|
2024
Q4 | $6.08M | Buy |
706,733
+618,523
| +701% | +$5.32M | ﹤0.01% | 3187 |
|
|
2024
Q3 | $1.5M | Hold |
88,210
| – | – | ﹤0.01% | 3645 |
|
|
2024
Q2 | $1.33M | Sell |
88,210
-8,870
| -9% | -$134K | ﹤0.01% | 3696 |
|
|
2024
Q1 | $1.61M | Sell |
97,080
-809
| -0.8% | -$13.4K | ﹤0.01% | 3661 |
|
|
2023
Q4 | $1.57M | Buy |
97,889
+374
| +0.4% | +$5.98K | ﹤0.01% | 3683 |
|
|
2023
Q3 | $7.43M | Buy |
97,515
+1,730
| +2% | +$132K | ﹤0.01% | 3066 |
|
|
2023
Q2 | $6.28M | Buy |
95,785
+63,987
| +201% | +$4.2M | ﹤0.01% | 3198 |
|
|
2023
Q1 | $1.9M | Hold |
31,798
| – | – | ﹤0.01% | 3695 |
|
|
2022
Q4 | $741K | Sell |
31,798
-83
| -0.3% | -$1.93K | ﹤0.01% | 3999 |
|
|
2022
Q3 | $1.07M | Hold |
31,881
| – | – | ﹤0.01% | 3976 |
|
|
2022
Q2 | $845K | Sell |
31,881
-4,207
| -12% | -$112K | ﹤0.01% | 4141 |
|
|
2022
Q1 | $1.06M | Sell |
36,088
-672
| -2% | -$19.8K | ﹤0.01% | 4185 |
|
|
2021
Q4 | $3.14M | Sell |
36,760
-1,015
| -3% | -$86.8K | ﹤0.01% | 3859 |
|
|
2021
Q3 | $2.82M | Buy |
37,775
+1,154
| +3% | +$86K | ﹤0.01% | 3940 |
|
|
2021
Q2 | $3.42M | Buy |
+36,621
| New | +$3.42M | ﹤0.01% | 3780 |
|